Eris Lifesciences [ERIS] vs Jubilant Pharmova [JUBLPHARMA] Detailed Comparison

TLDR: Quick Comparison Summary

Based on 13 vital metrics comparison: Eris Lifesciences wins in 6 metrics, Jubilant Pharmova wins in 7 metrics, with 0 ties. Jubilant Pharmova appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Eris Lifesciences Jubilant Pharmova Better
P/E Ratio (TTM) 62.90 21.22 Jubilant Pharmova
Price-to-Book Ratio 7.75 2.84 Jubilant Pharmova
Debt-to-Equity Ratio 75.74 43.78 Jubilant Pharmova
PEG Ratio 39.05 0.02 Jubilant Pharmova
EV/EBITDA 24.37 16.32 Jubilant Pharmova
Profit Margin 12.22% 11.60% Eris Lifesciences
Operating Margin 24.93% 12.97% Eris Lifesciences
EBITDA Margin 24.93% 12.97% Eris Lifesciences
Return on Equity 11.54% 14.35% Jubilant Pharmova
Return on Assets 6.23% 4.14% Eris Lifesciences
Free Cash Flow $9.10B $-435.00M Eris Lifesciences
Dividend Yield 0.41% 0.45% Jubilant Pharmova
1-Year Return 63.85% 59.74% Eris Lifesciences
Overview
Performance
Valuation
Financials
Short Interest
Dividends

Eris Lifesciences vs Jubilant Pharmova Price History Comparison

Key Statistics Comparison

Loading Statistics...

Performance

Eris Lifesciences vs Jubilant Pharmova Performance Comparison Chart

Loading Price Chart...

Performance Comparison

Loading Performance Data...

Valuation

Valuation History

Loading Valuation History...

Market Capitalization % Change

P/E Ratio (TTM)

Forward P/E

PEG Ratio

Price to Sales (TTM)

Price to Book (MRQ)

Enterprise Value % Change

EV/EBITDA

EV/Revenue

Valuation Metrics

Loading Valuation Metrics...

Financials

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement Comparison (TTM)

Loading Financials...

Short Interest And Ownership

Short Interest And Ownership Metrics

Loading Short Interest And Ownership Data...

Dividends

Dividend Information

Loading Dividend Information...